Latest filings (excl ownership)
8-K
Other Events
1 Sep 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
12 May 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
28 Jun 22
10-Q
2022 Q1
Quarterly report
23 May 22
DEFA14A
Additional proxy soliciting materials
17 May 22
NT 10-Q
Notice of late quarterly filing
4 May 22
DEFA14A
Additional proxy soliciting materials
3 May 22
DEF 14A
Definitive proxy
3 May 22
10-K
2021 FY
Annual report
15 Apr 22
NT 10-K
Notice of late annual filing
23 Mar 22
8-K
IONIQ Sciences Announces Acquisition of Intellectual Property and Buyout of License
8 Mar 22
8-K
IONIQ Sciences Announces Submission of De Novo Application to FDA
3 Feb 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
8-K
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors
7 Oct 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
8-K
Submission of Matters to a Vote of Security Holders
14 Jul 21
DEFA14A
Additional proxy soliciting materials
2 Jun 21
8-K
Unregistered Sales of Equity Securities
28 May 21
DEFA14A
Additional proxy soliciting materials
25 May 21
DEF 14A
Definitive proxy
25 May 21
10-Q
2021 Q1
Quarterly report
24 May 21
PRE 14A
Preliminary proxy
14 May 21
10-K
2020 FY
Annual report
3 May 21
10-Q
2020 Q3
Quarterly report
16 Mar 21
D
$6M in debt, sold $182K, 4 investors
21 Dec 20
10-Q
2020 Q2
Quarterly report
16 Sep 20
10-Q
2020 Q1
Quarterly report
25 Aug 20
10-K
2019 FY
Annual report
15 Jul 20
8-K
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
28 May 20
8-K
Unregistered Sales of Equity Securities
22 May 20
10-Q
2019 Q3
Quarterly report
8 May 20
8-K
Changes in Registrant's Certifying Accountant
10 Mar 20
10-Q
2019 Q2
Quarterly report
4 Mar 20
8-K
Submission of Matters to a Vote of Security Holders
27 Feb 20
Latest ownership filings
4
STEVEN C EROR
30 Aug 18
SC 13D/A
Prolung Inc
21 Aug 18
3
Jared Bauer
16 Aug 18
SC 13D/A
Prolung Inc
7 Aug 18
3
STEVEN C EROR
7 Aug 18
SC 13D/A
Prolung Inc
31 Jul 18
4
Neil Berkley
29 May 18
3
Neil Berkley
14 May 18
4
Robin L Smith
14 May 18
4
Neil Berkley
14 May 18
4
STEVEN C EROR
11 May 18
4
J Scott Nixon
11 May 18
4
John C Ruckdeschel
11 May 18
4
Todd M Morgan
11 May 18
4
ROBERT W RAYBOULD
11 May 18
SC 13D/A
Prolung Inc
4 Jan 18
3/A
ROBERT W RAYBOULD
2 Jan 18
4
ROBERT W RAYBOULD
2 Jan 18
4
Mark V Anderson
15 Nov 17
4
Michael Garff
13 Nov 17
4
STEVEN C EROR
13 Nov 17
4
Robin L Smith
30 Aug 17
4
ROBERT W RAYBOULD
29 Aug 17
4
J Scott Nixon
29 Aug 17
4
John C Ruckdeschel
28 Aug 17
4
Todd M Morgan
28 Aug 17
4
STEVEN C EROR
28 Aug 17
3
Mark V Anderson
30 Jun 17
3
J Scott Nixon
14 Jun 17
3
Robin L Smith
14 Jun 17
3/A
Robin L Smith
14 Jun 17
4
Robin L Smith
14 Jun 17
4/A
Robin L Smith
14 Jun 17
3
John C Ruckdeschel
9 Jun 16
5
Todd M Morgan
2 Jun 16
SC 13D
Fresh Medical Laboratories, Inc.
24 May 16
5
Todd M Morgan
20 May 16
3
Todd M Morgan
17 May 16
3
Jeffrey S. O'Driscoll
22 Apr 16
5
Jeffrey S. O'Driscoll
22 Apr 16